Treatment satisfaction and quality-of-life between type 2 diabetes patients initiating long- vs. intermediate-acting basal insulin therapy in combination with oral hypoglycemic agents – a randomized, prospective, crossover, open clinical trial

BACKGROUND: Pharmacological and clinical differences between insulin glargine and NPH insulin may translate into differences in patient reported outcomes, but existing data are equivocal. METHODS: In this 48-week, open-label, randomized, multi-center, crossover phase IV trial, insulin naïve type 2 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermanns, Norbert, Kulzer, Bernd, Kohlmann, Thomas, Jacob, Stephan, Landgraf, Wolfgang, Theobald, Karlheinz, Haak, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459660/
https://www.ncbi.nlm.nih.gov/pubmed/26055391
http://dx.doi.org/10.1186/s12955-015-0279-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459660/
https://www.ncbi.nlm.nih.gov/pubmed/26055391
http://dx.doi.org/10.1186/s12955-015-0279-4

Ejemplares similares